4.50 - Ivosidenib & Aza vs Aza, the AGILE, 6 huge problems; Journal club

I perform an analysis of the AGILE trial that came out in NEJM today; I find 6 huge problems. Follow PS on twitter; and write to us to let us know what you think

Om Podcasten

A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California, San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.